These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

344 related items for PubMed ID: 25866271

  • 1. Aptamer-targeted oligonucleotide theranostics: a smarter approach for brain delivery and the treatment of neurological diseases.
    Sriramoju B, Kanwar R, Veedu RN, Kanwar JR.
    Curr Top Med Chem; 2015; 15(12):1115-24. PubMed ID: 25866271
    [Abstract] [Full Text] [Related]

  • 2. Aptamers in targeted nanotherapy.
    Mathew A, Maekawa T, Sakthikumar D.
    Curr Top Med Chem; 2015; 15(12):1102-14. PubMed ID: 25866269
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Recent Advances in SELEX Technology and Aptamer Applications in Biomedicine.
    Zhuo Z, Yu Y, Wang M, Li J, Zhang Z, Liu J, Wu X, Lu A, Zhang G, Zhang B.
    Int J Mol Sci; 2017 Oct 14; 18(10):. PubMed ID: 29036890
    [Abstract] [Full Text] [Related]

  • 5. Aptamers: molecular tools for medical diagnosis.
    Ozalp VC, Kavruk M, Dilek O, Bayrac AT.
    Curr Top Med Chem; 2015 Oct 14; 15(12):1125-37. PubMed ID: 25866272
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Aptamers as theranostic agents: modifications, serum stability and functionalisation.
    Shigdar S, Macdonald J, O'Connor M, Wang T, Xiang D, Al Shamaileh H, Qiao L, Wei M, Zhou SF, Zhu Y, Kong L, Bhattacharya S, Li C, Duan W.
    Sensors (Basel); 2013 Oct 10; 13(10):13624-37. PubMed ID: 24152925
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Aptamers as Versatile Ligands for Biomedical and Pharmaceutical Applications.
    Guan B, Zhang X.
    Int J Nanomedicine; 2020 Oct 10; 15():1059-1071. PubMed ID: 32110008
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Nanotechnology and aptamers: applications in drug delivery.
    Levy-Nissenbaum E, Radovic-Moreno AF, Wang AZ, Langer R, Farokhzad OC.
    Trends Biotechnol; 2008 Aug 10; 26(8):442-9. PubMed ID: 18571753
    [Abstract] [Full Text] [Related]

  • 16. Superior Performance of Aptamer in Tumor Penetration over Antibody: Implication of Aptamer-Based Theranostics in Solid Tumors.
    Xiang D, Zheng C, Zhou SF, Qiao S, Tran PH, Pu C, Li Y, Kong L, Kouzani AZ, Lin J, Liu K, Li L, Shigdar S, Duan W.
    Theranostics; 2015 Aug 10; 5(10):1083-97. PubMed ID: 26199647
    [Abstract] [Full Text] [Related]

  • 17. Advances and perspectives in cell-specific aptamers.
    Sun W, Du L, Li M.
    Curr Pharm Des; 2011 Aug 10; 17(1):80-91. PubMed ID: 21342116
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Chimeric aptamers in cancer cell-targeted drug delivery.
    Kanwar JR, Roy K, Kanwar RK.
    Crit Rev Biochem Mol Biol; 2011 Dec 10; 46(6):459-77. PubMed ID: 21955150
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.